Loading profile…
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.
Pulling IRS BMF, Form 990 filings, peer benchmarks, programs, people, and grants.

DBA: N/A
EIN 22-2480896 · Snapshot of IRS recognition, filing currency, financial health, and governance.
To support the development of new drugs to treat Charcot-Marie-Tooth disease (cmt), to improve the quality of life for people with cmt and ultimately, to fund a cure.
Total Revenue
$6.9M
FY2025
Total Expenses
$7.4M
FY2025
Net Assets
$6.1M
Program Ratio
90.7%
expenses on programs
Employees
14
Volunteers
125
Board Members
17
Voting
17
Independent
8 answers compiled from IRS Form 990, BMF, Pub 78, and the Auto-Revocation List.